Red cell distribution width, inflammatory markers and cardiorespiratory fitness: Results from the National Health and Nutrition Examination Survey

Indian Heart Journal

Volumn 64, Issue 4, 2012, Pages 380-387

  Agarwal, Shikhar ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

C reactive protein; Complex survey analysis; Examination survey; Exercise capacity; National health and nutrition; Red cell distribution width

Indexed keywords

C REACTIVE PROTEIN; OXYGEN;

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; ERYTHROCYTE COUNT; EXERCISE; FEMALE; HEART RATE; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

EID: 84870763913     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ihj.2012.06.006     Document Type: Article

References (31)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statisticse2011 update: a report from the American Heart Association. Circulation. 2011; 123: e18-e209.
2. Blair SN, Kohl 3rd HW, Barlow CE, et al. Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men. JAMA. 1995; 273: 1093-1098.
3. Berry JD, Willis B, Gupta S, et al. Lifetime risks for cardiovascular disease mortality by cardiorespiratory fitness levels measured at ages 45, 55, and 65 years in men. The Cooper Center Longitudinal Study. J Am Coll Cardiol. 2011; 57: 1604-1610.
4. Ekelund LG, Haskell WL, Johnson JL, et al. Physical fitness as a predictor of cardiovascular mortality in asymptomatic North American men. The Lipid Research Clinics Mortality Follow-up Study. N Engl J Med. 1988; 319: 1379-1384.
5. Kodama S, Saito K, Tanaka S, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta- analysis. JAMA. 2009; 301: 2024-2035.
6. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997; 336: 973-979.
7. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002; 105: 1135-1143.
8. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004; 350: 1387-1397.
9. Berliner JA, Navab M, Fogelman AM, et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation. 1995; 91: 2488-2496.
10. van Kimmenade RR, Mohammed AA, Uthamalingam S, van der Meer P, Felker GM, Januzzi Jr JL. Red blood cell distribution width and 1-year mortality in acute heart failure. Eur J Heart Fail. 2010; 12: 129-136.
11. Dabbah S, Hammerman H, Markiewicz W, Aronson D. Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. Am J Cardiol. 2010; 105: 312-317.
12. Patel KV, Ferrucci L, Ershler WB, Longo DL, Guralnik JM. Red blood cell distribution width and the risk of death in middle- aged and older adults. Arch Intern Med. 2009; 169: 515-523.
13. Tonelli M, Sacks F, Arnold M, et al for the Cholesterol and Recurrent Events (CARE) Trial Investigators. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation. 2008; 117: 163-168.
14. Ghaffari S. Oxidative stress in the regulation of normal and neoplastic hematopoiesis. Antioxid Redox Signal. 2008; 10: 1923-1940.
15. http://www.cdc.gov/nchs/nhanes/nhanes_questionnaires.htm; Accessed 22. 12. 11.
16. American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription. 6th ed. Philadelphia, PA: Lippincott Williams and Wilkins Company; 1995.
17. Blair SN, Kohl 3rd HW, Paffenbarger Jr RS, et al. Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA. 1989; 262: 2395-2401.
18. Cureton KJ, Warren GL. Criterion-referenced standards for youth health-related fitness tests: a tutorial. Res Q Exerc Sport. 1990; 6: 7-19.
19. Cureton KJ, Plowman SA. Aerobic capacity assessments. In: Welk GJ, Morrow JR Jr, Falls HB, eds. Fitnessgram Reference Guide. Dallas, TX: Cooper Institute. http://dev.cooperinst.org/shopping/PDF%20format/Fitnessgram%20Reference%20Guide.pdf; Accessed 16. 01. 12.
20. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation classification and stratification. Ann Intern Med. 2003; 139: 137-147.
21. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007; 298: 2038-2047.
22. Selvin S, Manzi J, Stevens LA, et al. Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis. 2007; 50: 918-926.
23. Felker GM, Allen LA, Pocock SJ, et al; CHARM investigators. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol. 2007; 50: 40-47.
24. Zalawadiya SK, Zmily H, Farah J, Daifallah S, Ali O, Ghali JK. Red cell distribution width and mortality in predominantly African-American population with decompensated heart failure. J Card Fail. 2011; 17: 292-298.
25. Pascual-Figal DA, Bonaque JC, Redondo B, et al. Red blood cell distribution width predicts long-term outcome regardless of anaemia status in acute heart failure patients. Eur J Heart Fail. 2009; 11: 840-846.
26. Jackson CE, Dalzell JR, Bezlyak V, et al. Red cell distribution width has incremental prognostic value to B-type natriuretic peptide in acute heart failure. Eur J Heart Fail. 2009; 11: 1152-1154.
27. Perkins SL. Examination of Blood and Bone Marrow. Wintrobe's Clinical Hematology. 11th ed. Salt Lake City: Lippincott Wilkins & Williams; 2003. 5-25.
28. Tsimikas S, Willerson JT, Ridker PM. C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. J Am Coll Cardiol. 2006; 47: C19-C31.
29. Ghali JK. Anemia and heart failure. Curr Opin Cardiol. 2009; 24: 172-178.
30. Ridker PM, Rifai N, Pfeffer MA, et al. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation. 1998; 98: 839-844.
31. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002; 346: 793-801.